HaeWon ChungSenior Synthetic Biologist at AsimovSpeaker
HaeWon currently serves as the Senior Scientist at Asimov, where he spearheads the advancement of the CHO edge platform. His professional journey commenced at Sanofi, where, as a postdoctoral fellow, he delved into the analysis of integration sites and the creation of landing pad cell lines. Since joining Asimov, HaeWon has played a pivotal role in shaping comprehensive procedures for cell line development. This encompasses tasks such as generating GS knockout CHO host cells, formulating diverse vector strategies with varying chain ratios and GS attenuation levels, assessing codon optimization, and conducting screenings for signal peptides. Embracing a passion for innovative thinking, he consistently seeks to transcend conventional boundaries in cell line development through cutting-edge synthetic biology techniques.